Search clinical trials for: ACTIVA BioACTIVE-RESTORATIVE

Total 10000 results

Prof. Dr. med. Max. E. Scheulen
ClinAssess GmbH

Unknown

A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma (STREAM)

Uveal Melanoma

Germany
Niguarda Hospital

Completed

Effects of Imatinib Mesylate in Polycythemia Vera

Polycythemia Vera
Boehringer Ingelheim

Completed

Safe Implementation of Thrombolysis in Stroke - Monitoring Study

Stroke
AstraZeneca

Completed

Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours

Hepatic Impairment | Advanced Cancer

Netherlands, Denmark
Bayer

Completed

Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator (DIGIT)

Raynaud Disease

Germany
National Institute of Allergy and Infectious Diseases...
University of Oxford; Wellcome Trust; World Health Organization

Completed

High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza

Influenza | Avian Influenza | Severe Influenza

Singapore, Thailand, Vietnam
University Hospital, Angers

Completed

Study to Assess Dasatinib in Patients With Core Binding Factors Acute Myelogenous Leukemia (DasaCBF)

Acute Myelogenous Leukemia

France
GlaxoSmithKline

Completed

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Cancer

United States, France, Germany, Belgium
Genzyme, a Sanofi Company

Completed

Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors

Solid Tumors

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI); Schering-Plough

Completed

Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer

Lung Cancer

United States
University of California, San Francisco
National Cancer Institute (NCI)

Unknown

UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer

Kidney Cancer

United States
Boehringer Ingelheim

Completed

Influence of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Various Doses of Afatinib

Liver Diseases | Healthy

Germany
University of Medicine and Dentistry of New Jersey
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Pathogen Specific Immunity in Patients With Sarcoidosis

Sarcoidosis

United States
Massachusetts General Hospital

Completed

PhotoDynamic Therapy for Line Infection Prevention (PLIP): Pilot Study on Healthy Volunteers.

Light; Therapy, Complications
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Terminated

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

Chondrosarcoma | Adult Rhabdomyosarcoma | Adult Fibrosarcoma | Adult Leiomyosarcoma | Adult Malignant Meningioma | Adult Brain Malignant Hemangiopericytoma

United States, Australia, Peru, Puerto Rico
Eisai Inc.

Completed

A Open-label, Three-period, Partial-replicate Design Study to Evaluate the Inter- and Intrasubject Variability of the Avatrombopag To-be-marketed Formulation Administered as Single Doses of 40 mg to Healthy Subjects Receiving a Low-fat Meal

Healthy Volunteers

United States
Takeda

Completed

Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican Adults

Erectile Dysfunction | Phosphodiesterase 5 Inhibitor

Mexico
Seoul National University Bundang Hospital

Completed

Heparin Solution and INTEM/HEPTEM Analysis

Brain Tumor | Spinal Stenosis | Cerebral Artery Anuerysm

Korea, Republic of
Gemin X

Completed

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes

Canada, United States
University of Manitoba
Winnipeg Regional Health Authority

Unknown

18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology

Tumors

Canada
University of Oxford

Withdrawn

Oseltamivir for Influenza Lower Respiratory Tract Infection in Children Under One

Influenza

Thailand
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer

Lung Cancer

United States
Texas Children's Cancer Center
National Cancer Institute (NCI)

Completed

Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors

Brain and Central Nervous System Tumors

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Decitabine in Treating Patients With Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia

United States
New Approaches to Brain Tumor Therapy Consortium
National Cancer Institute (NCI)

Completed

Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse

Brain and Central Nervous System Tumors

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
Vejle Hospital
Aarhus University Hospital

Terminated

Predictive Value of 18F-FAZA in Rectum Cancer (FAZA)

Locally Advanced Rectum Cancer

Denmark
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin

Testicular Germ Cell Tumor | Ovarian Cancer

United States
Eisai Inc.

Completed

Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

United States
CytRx

Completed

Study of Bafetinib as Treatment for Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

B-Cell Chronic Lymphocytic Leukemia

United States
Cancer Therapeutics Research Group
National Cancer Institute (NCI)

Completed

Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer

Gastric Cancer

Australia, Singapore, Hong Kong, Korea, Republic of
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Terminated

Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma

Brain Tumors | Central Nervous System Tumors | Leptomeningeal Metastases

United States
Center for Health, Exercise and Sport Sciences,...

Completed

Characterization and Detection of Prolonged Endothelin Receptors Antagonists Administration (ERAATH)

Pulmonary Hypertension

Serbia
Amgen

Completed

Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy

Stomatitis
Rigshospitalet, Denmark
Aarhus University Hospital; Bispebjerg Hospital; Actelion

Completed

Study of Placebo or Bosentan to Treat Patients With Single Ventricle Physiology. (TEMPO)

Tricuspid Atresia | Hypoplastic Left Heart Syndrome | Other Specified Congenital Anomalies of Heart

Denmark, Sweden
University of Cincinnati
Actelion

Completed

Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension (BOSAPAH)

Pulmonary Arterial Hypertension | Sarcoidosis

United States
University of California, Davis
Bayer

Completed

Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall

Soft Tissue Sarcoma

United States
Italian Sarcoma Group

Completed

Sorafenib in Relapsed High Grade Osteosarcoma

Osteosarcoma

Italy
The First Affiliated Hospital of Soochow University
Xian-Janssen Pharmaceutical Ltd.

Unknown

Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Myelodysplastic Syndromes | Acute Myelocytic Leukemia

China
California Cancer Consortium
National Cancer Institute (NCI)

Completed

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition

United States
Pfizer

Completed

A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease

Crohn's Disease

Netherlands, United States, Hungary, Belgium, Czech Republic, Italy, South Africa, Spain, United Kingdom, Slovakia, Poland, France
University College Cork

Completed

Study to Compare Milk Protein Isolate (MPI) With Caseinate in Terms of Protein Utilization

Enteral Feeds

Ireland
Duke University
Celgene Corporation

Completed

Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients

Primary Brain Tumor

United States
National Cancer Institute (NCI)

Withdrawn

Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma

Lymphoma | Solid Tumors
GlaxoSmithKline

Completed

Survey on the Pharmacy Follow-up of Alli Purchasers

Overweight
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer

United States
AstraZeneca

Completed

SELINE: Second-Line Iressa Phase IV Study in NSCLC Patients (SELINE)

Non Small Cell Lung Carcinoma

Korea, Republic of
European Organisation for Research and Treatment...

Completed

Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors

Brain and Central Nervous System Tumors

France, Switzerland, Belgium, Germany, Italy, United Kingdom, Netherlands, Portugal, Slovakia
European Organisation for Research and Treatment...

Completed

Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma

Sarcoma

France, Belgium, United Kingdom, Netherlands

Search clinical trials for: ACTIVA BioACTIVE-RESTORATIVE

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations